(R)-Methanandamide and Δ9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A

Torbjörn U C Järbe, Richard J Lamb, Qian Liu, Alexandros Makriyannis

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The current study examined the interaction between the cannabinoid CB1 receptor agonists Δ9-tetrahydrocannabinol and (R)-methanandamide in combination with the cannabinoid CB1 receptor antagonist SR-141716A (N-(piperidin-1-yl)-5-(4-chloro-phenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H- pyrazole-3-carboxamide HCl) in rats responding for food on a fixed ratio (FR-10) schedule of food reinforcement. The study provided only limited evidence for antagonism by SR-141716A (at 1 mg/kg but not with 0.3, 3 and 10 mg/kg) of the rate suppressant effects induced by the cannabinoid CB1 receptor agonist Δ9-tetrahydrocannabinol (and only at the single dose of 5.6 mg/kg Δ9-tetrahydrocannabinol). (R)-Methanandamide in combination with SR-141716A resulted in a greater rate suppression compared to that induced by (R)-methanandamide alone. Thus, SR-141716A augmented the rate-decreasing effects of (R)-methanandamide and only minimally altered the rate-decreasing effects of Δ9-tetrahydrocannabinol. Additionally, high doses (10 and 30 mg/kg) of SR-141716 singly consistently suppressed the rate of responding. The current results coupled with our previous data examining combinations of Δ9-tetrahydrocannabinol or (R)-methanandamide and SR-141716 (see text) underscore pharmacological/behavioral differences (whether quantitative or qualitative) between the cannabinoid CB1 agonists (R)-methanandamide and Δ9-tetrahydrocannabinol revealed by their interactions with the cannabinoid CB1 antagonist SR-141716.

Original languageEnglish (US)
Pages (from-to)121-127
Number of pages7
JournalEuropean Journal of Pharmacology
Volume466
Issue number1-2
DOIs
StatePublished - Apr 11 2003

Fingerprint

rimonabant
Dronabinol
Cannabinoid Receptor Agonists
Cannabinoid Receptor Antagonists
Reinforcement Schedule
Food
methanandamide

Keywords

  • Δ-Tetrahydrocannabinol
  • (R)-Methanandamide
  • (Rat)
  • Behavior, schedule controlled
  • Cannabinoid
  • SR-141716A

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

(R)-Methanandamide and Δ9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A. / Järbe, Torbjörn U C; Lamb, Richard J; Liu, Qian; Makriyannis, Alexandros.

In: European Journal of Pharmacology, Vol. 466, No. 1-2, 11.04.2003, p. 121-127.

Research output: Contribution to journalArticle

Järbe, Torbjörn U C ; Lamb, Richard J ; Liu, Qian ; Makriyannis, Alexandros. / (R)-Methanandamide and Δ9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A. In: European Journal of Pharmacology. 2003 ; Vol. 466, No. 1-2. pp. 121-127.
@article{c57911f4262f417ea521a793f0df9164,
title = "(R)-Methanandamide and Δ9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A",
abstract = "The current study examined the interaction between the cannabinoid CB1 receptor agonists Δ9-tetrahydrocannabinol and (R)-methanandamide in combination with the cannabinoid CB1 receptor antagonist SR-141716A (N-(piperidin-1-yl)-5-(4-chloro-phenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H- pyrazole-3-carboxamide HCl) in rats responding for food on a fixed ratio (FR-10) schedule of food reinforcement. The study provided only limited evidence for antagonism by SR-141716A (at 1 mg/kg but not with 0.3, 3 and 10 mg/kg) of the rate suppressant effects induced by the cannabinoid CB1 receptor agonist Δ9-tetrahydrocannabinol (and only at the single dose of 5.6 mg/kg Δ9-tetrahydrocannabinol). (R)-Methanandamide in combination with SR-141716A resulted in a greater rate suppression compared to that induced by (R)-methanandamide alone. Thus, SR-141716A augmented the rate-decreasing effects of (R)-methanandamide and only minimally altered the rate-decreasing effects of Δ9-tetrahydrocannabinol. Additionally, high doses (10 and 30 mg/kg) of SR-141716 singly consistently suppressed the rate of responding. The current results coupled with our previous data examining combinations of Δ9-tetrahydrocannabinol or (R)-methanandamide and SR-141716 (see text) underscore pharmacological/behavioral differences (whether quantitative or qualitative) between the cannabinoid CB1 agonists (R)-methanandamide and Δ9-tetrahydrocannabinol revealed by their interactions with the cannabinoid CB1 antagonist SR-141716.",
keywords = "Δ-Tetrahydrocannabinol, (R)-Methanandamide, (Rat), Behavior, schedule controlled, Cannabinoid, SR-141716A",
author = "J{\"a}rbe, {Torbj{\"o}rn U C} and Lamb, {Richard J} and Qian Liu and Alexandros Makriyannis",
year = "2003",
month = "4",
day = "11",
doi = "10.1016/S0014-2999(03)01491-2",
language = "English (US)",
volume = "466",
pages = "121--127",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - (R)-Methanandamide and Δ9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A

AU - Järbe, Torbjörn U C

AU - Lamb, Richard J

AU - Liu, Qian

AU - Makriyannis, Alexandros

PY - 2003/4/11

Y1 - 2003/4/11

N2 - The current study examined the interaction between the cannabinoid CB1 receptor agonists Δ9-tetrahydrocannabinol and (R)-methanandamide in combination with the cannabinoid CB1 receptor antagonist SR-141716A (N-(piperidin-1-yl)-5-(4-chloro-phenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H- pyrazole-3-carboxamide HCl) in rats responding for food on a fixed ratio (FR-10) schedule of food reinforcement. The study provided only limited evidence for antagonism by SR-141716A (at 1 mg/kg but not with 0.3, 3 and 10 mg/kg) of the rate suppressant effects induced by the cannabinoid CB1 receptor agonist Δ9-tetrahydrocannabinol (and only at the single dose of 5.6 mg/kg Δ9-tetrahydrocannabinol). (R)-Methanandamide in combination with SR-141716A resulted in a greater rate suppression compared to that induced by (R)-methanandamide alone. Thus, SR-141716A augmented the rate-decreasing effects of (R)-methanandamide and only minimally altered the rate-decreasing effects of Δ9-tetrahydrocannabinol. Additionally, high doses (10 and 30 mg/kg) of SR-141716 singly consistently suppressed the rate of responding. The current results coupled with our previous data examining combinations of Δ9-tetrahydrocannabinol or (R)-methanandamide and SR-141716 (see text) underscore pharmacological/behavioral differences (whether quantitative or qualitative) between the cannabinoid CB1 agonists (R)-methanandamide and Δ9-tetrahydrocannabinol revealed by their interactions with the cannabinoid CB1 antagonist SR-141716.

AB - The current study examined the interaction between the cannabinoid CB1 receptor agonists Δ9-tetrahydrocannabinol and (R)-methanandamide in combination with the cannabinoid CB1 receptor antagonist SR-141716A (N-(piperidin-1-yl)-5-(4-chloro-phenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H- pyrazole-3-carboxamide HCl) in rats responding for food on a fixed ratio (FR-10) schedule of food reinforcement. The study provided only limited evidence for antagonism by SR-141716A (at 1 mg/kg but not with 0.3, 3 and 10 mg/kg) of the rate suppressant effects induced by the cannabinoid CB1 receptor agonist Δ9-tetrahydrocannabinol (and only at the single dose of 5.6 mg/kg Δ9-tetrahydrocannabinol). (R)-Methanandamide in combination with SR-141716A resulted in a greater rate suppression compared to that induced by (R)-methanandamide alone. Thus, SR-141716A augmented the rate-decreasing effects of (R)-methanandamide and only minimally altered the rate-decreasing effects of Δ9-tetrahydrocannabinol. Additionally, high doses (10 and 30 mg/kg) of SR-141716 singly consistently suppressed the rate of responding. The current results coupled with our previous data examining combinations of Δ9-tetrahydrocannabinol or (R)-methanandamide and SR-141716 (see text) underscore pharmacological/behavioral differences (whether quantitative or qualitative) between the cannabinoid CB1 agonists (R)-methanandamide and Δ9-tetrahydrocannabinol revealed by their interactions with the cannabinoid CB1 antagonist SR-141716.

KW - Δ-Tetrahydrocannabinol

KW - (R)-Methanandamide

KW - (Rat)

KW - Behavior, schedule controlled

KW - Cannabinoid

KW - SR-141716A

UR - http://www.scopus.com/inward/record.url?scp=0037432641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037432641&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(03)01491-2

DO - 10.1016/S0014-2999(03)01491-2

M3 - Article

C2 - 12679148

AN - SCOPUS:0037432641

VL - 466

SP - 121

EP - 127

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-2

ER -